<DOC>
	<DOCNO>NCT00945919</DOCNO>
	<brief_summary>This project explore safety feasibility perform successful intravenous patient control analgesia ( IV PCA ) Oxymorphone titration conversion oral ER Oxymorphone ( extended release OPANA ER ) outpatient setting .</brief_summary>
	<brief_title>A Pilot Study Ultra Rapid Opioid Rotation Titration Oxymorphone</brief_title>
	<detailed_description>This project enroll 12 volunteer suffer chronic pain . Potential participant must one follow therapy : - Long act morphine - Oxycodone Participants ask complete pain diary approximately 10 day stop take current pain medication night admit GCRC . Once patient present GCRC , start IV PCA ( Patient Controlled Analgesia ) Oxymorphone control pain . Titration take approximately total 8 hr . At end titration period , patient discharge home OPANA ER . The oral dose calculate base IV PCA use . During titration , patient ' pain , vital side effect assess hourly 8th hour IV PCA titration . Patients contact daily member study team ass pain side effect . The OPANA ER dose adjust need adequately manage . If patient feel though get adequate pain relief , return previous medication , point consider withdrawn study . Patients undergo exit examination 2 week admit GCRC order ass pain relief . In addition , final follow-up telephone interview take place 6 week initial 1-day stay GCRC . Our research staff physicians ask pain treatment ask Opioid medication currently take .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Nociceptive Pain</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Oxymorphone</mesh_term>
	<criteria>18 year age old . Chronic pain nociceptive , neuropathic , mixed origin . Patients chronic noncancer pain . Ongoing chronic Opioid treatment either oral morphine oxycodone ( long termâ€”more three month least total daily Opioid dose 60mg morphine 30 mg oxycodone ) . Pain moderate intensity ( &gt; = 4 , numerical scale 010 ) despite ongoing Opioid therapy . Nonpregnant , nonlactating woman . Sufficient language skill communicate research staff . Nonambulatory patient . Clinically significant respiratory , renal , hepatic , cardiac disease . Documented diagnosis sleep apnea ( study physician may exclude patient present clinical feature complaint suggestive diagnosis probably sleep apnea ) . History illicit drug alcohol dependence abuse , abnormal drug taking/seeking behavior . Sever depression ( &gt; 26 BDI ) severe anxiety insomnia require chronic daily use benzodiazepine hypnotic drug . Patients exhibit score Mini Mental Status Exam ( MMSE ) 26 less . ( The range score mild dementia 2126 MMSE ) . Hypersensitivity study medication ( Oxymorphone ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Oral morphine</keyword>
	<keyword>oxycodone</keyword>
	<keyword>OPANA</keyword>
	<keyword>Oxymorphone</keyword>
	<keyword>pain</keyword>
	<keyword>nociceptive</keyword>
	<keyword>neuropathic</keyword>
	<keyword>rotation</keyword>
	<keyword>titration</keyword>
	<keyword>mixed origin non-cancer pain</keyword>
</DOC>